Quick Order Cart

Cat. No. ARG33257

GOPC Knockout HT29 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

GOPC Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the HT29 colon adenocarcinoma line, offering a loss-of-function model to study the Golgi-associated scaffold protein GOPC (CAL). GOPC regulates CFTR trafficking and cell polarity through interactions with STX6, GORASP1, and the Par complex proteins PARD3, PARD6A, and PRKCZ. This polyclonal knockout model is ideal for investigating CFTR degradation pathways, tight junction assembly, and epithelial polarity in intestinal epithelial contexts. Applications include western blotting, immunofluorescence, co-immunoprecipitation, barrier integrity assays, and migration studies, supporting research in cystic fibrosis and colorectal cancer.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HT29

    Gene Name

    GOPC

    Gene Identifier

    NCBI Gene ID 57120

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    McCoy's 5A

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

GOPC Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the Golgi-associated PDZ and coiled-coil motif-containing protein (GOPC, also known as CAL) in the HT29 human colon adenocarcinoma cell line. This loss-of-function model enables the investigation of GOPC-dependent pathways without introducing monoclonal selection bias, preserving the genetic heterogeneity inherent to polyclonal populations. The CRISPR/Cas9-mediated gene disruption provides a robust tool for studying GOPC’s roles in vesicular trafficking, cell polarity, and protein degradation mechanisms.

The HT29 cell line is a well-differentiated, epithelial model derived from a primary colorectal adenocarcinoma of a 44-year-old female. These cells retain characteristics of intestinal epithelial cells, including the capacity for mucus production and the formation of polarized monolayers with functional tight junctions. As a tumorigenic cell line, HT29 is widely used to study colorectal cancer biology, intestinal barrier function, and the molecular mechanisms underlying epithelial cell polarity and protein trafficking.

GOPC (CAL) functions as a Golgi-associated scaffold protein that critically regulates intracellular trafficking and cell polarity. It facilitates the lysosomal degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) by interacting with syntaxin 6 (STX6) and the Golgi reassembly stacking protein 1 (GORASP1), thereby controlling CFTR surface expression. Additionally, GOPC acts as a scaffold for the Par polarity complex, interacting with PARD3, PARD6A, and atypical protein kinase C (PRKCZ/??), which are essential for tight junction assembly and apical-basal polarity. Upstream signals from Golgi stress and cellular trafficking demands modulate GOPC activity, while downstream effects include the regulation of CFTR trafficking, vesicle tethering, and Golgi structural integrity. Key pathway components include CDC42, a small GTPase that activates the Par complex, further linking GOPC to actin cytoskeletal dynamics and polarity signaling.

In the HT29 intestinal epithelial context, loss of GOPC disrupts CFTR trafficking, potentially altering chloride secretion and mucus homeostasis, which are relevant to cystic fibrosis pathophysiology. Moreover, because HT29 cells form polarized monolayers, GOPC knockout perturbs the Par complex-mediated tight junction assembly, compromising epithelial barrier integrity and cell polarity. This dual impact makes the model particularly valuable for dissecting the molecular crosstalk between protein trafficking, polarity establishment, and tumorigenic properties in colorectal cancer.

Typical research applications include western blotting and immunofluorescence analysis of CFTR and tight junction proteins to assess trafficking and localization defects, co-immunoprecipitation studies to map GOPC interactor networks, and barrier integrity assays such as transepithelial electrical resistance (TEER) measurements. Additionally, migration and invasion assays can explore the role of GOPC in metastatic behavior. This polyclonal knockout cell population thus provides a versatile platform for mechanistic studies in cell biology and drug discovery. For technical specifications or ordering information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)